Loading...

Expanding Dermatology Pipeline Will Unlock Future Treatment Horizons

Published
22 Jul 25
AnalystConsensusTarget's Fair Value
€13.30
5.6% undervalued intrinsic discount
22 Jul
€12.56
Loading
1Y
37.0%
7D
4.5%

Author's Valuation

€13.35.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value